Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$0.04
EPS est.
$0.01
EPS surprise
+300.00%
1-day move
+20.24%
LifeStance Health reported a lower-than-expected EPS but still managed to beat consensus estimates, which contributed to a strong stock reaction, rising 20.24%. The lack of revenue data leaves some uncertainty about overall performance. Investors may be reacting positively to the EPS surprise despite the missing revenue figures.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.04 | $0.06 | +300.00% |
| Revenue | — | $386M | — |
No transcript is on record, and the analysis is based on numerical results only.
LifeStance Health Group, Inc. is a healthcare services company focused on providing mental health care. With a market cap of $3 billion, it plays a crucial role in addressing the growing demand for mental health services, especially as awareness and acceptance of mental health issues increase.
Last quarter
In the last quarter, LifeStance reported an EPS of $0.02, significantly beating expectations. The stock reacted positively, gaining 3.78% the following day.
Management promises and guidance
EPS beat streak
6Q
EPS beat rate
88%
Avg EPS surprise
+153.88%
Avg 1-day reaction
+6.33%
Analysts expect LifeStance to report a modest profit this quarter, with a focus on revenue growth amidst a competitive healthcare landscape.
Bull case
If LifeStance beats EPS estimates and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth trajectory and market position.
Key metrics to watch
EPS
$0.06Earnings per share is a key indicator of profitability and will show how well the company is managing its costs.
Revenue
$386MRevenue growth is essential for assessing the company's ability to expand its services and market presence.
The print will turn on these.
Q1
Will the EPS exceed the consensus estimate of $0.06?
A beat on EPS could indicate stronger-than-expected profitability and boost investor confidence.
Q2
How will revenue compare to the consensus of $386M?
Revenue performance is crucial for understanding the company's growth and market demand for its services.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±6.9%
Why consensus could be wrong
The Street may be underestimating the potential for LifeStance to exceed revenue expectations due to increasing demand for mental health services.
Supporting evidence
The company's recent growth in patient numbers suggests a stronger revenue outlook than consensus estimates.
Options pricing indicates a higher expected move, reflecting market anticipation of significant news.
Key risk
If revenue comes in below $370M, it could undermine the bullish sentiment surrounding the stock.
Pre-commit to what would confirm each case.
This quarter's results will be pivotal in determining whether LifeStance can sustain its growth trajectory amidst increasing competition.
Bull confirmed if
An EPS of $0.08 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $0.04 would raise concerns about profitability and growth potential.
What the market is pricing for the move.
Implied Move
±11.58%
Historical Avg
±10.6%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±11.6% while LFST has averaged ±10.6% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.9%
30d HV
35.4%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: X of Y (Z%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 3.3%, with a raw directional average of +2.1% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
91.07%
of float
Insider
3.07%
of float
Holders
403
institutions
Top Holders· as of Jun 2026
TPG GP A, LLC
111,744,614 sh · $1.4B
29.24%
-20.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If LifeStance beats expectations, history suggests the stock could rise by around 4.88%, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.
Miss
A miss could lead to a decline of approximately 3.06%, reflecting investor disappointment and concerns about future growth.
The lines on the call that would change the story.
FMR, LLC
58,252,466 sh · $705.4M
15.24%
-0.7%
Blackrock Inc.
36,348,507 sh · $440.2M
9.51%
100.4%
Summit Partners, L.P.
23,310,115 sh · $282.3M
6.10%
-20.2%
Vanguard Portfolio Management LLC
13,960,892 sh · $169.1M
3.65%
44.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.